
Sign up to save your podcasts
Or


Adam and Adir discuss the withdrawal of support for prestigious colleges in the US in the midst of the Israel crisis, the incredible rise of GLP-1 drugs Ozempic and Wegovy and Atlassian’s purchase of video sharing app Loom. Plus, TWO difficult experience with UberEats and the value of paying staff with company stock.
See omnystudio.com/listener for privacy information.
By Adam Schwab and Adir Shiffman5
22 ratings
Adam and Adir discuss the withdrawal of support for prestigious colleges in the US in the midst of the Israel crisis, the incredible rise of GLP-1 drugs Ozempic and Wegovy and Atlassian’s purchase of video sharing app Loom. Plus, TWO difficult experience with UberEats and the value of paying staff with company stock.
See omnystudio.com/listener for privacy information.

14 Listeners

87 Listeners

23 Listeners

47 Listeners

15 Listeners

65 Listeners

29 Listeners

23 Listeners

4 Listeners

5 Listeners

10 Listeners

33 Listeners

10 Listeners

17 Listeners

16 Listeners